在患有重大抑郁症患者中,中心周围对比抑制的改变
Kathrin Nickel1, Sven P Heinrich2, Malina Beringer3
1Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. kathrin.nickel@uniklinik-freiburg.de.
Scientific reports
|November 15, 2024
概括
患有严重抑郁症 (MDD) 患者的对比度抑制减少,影响视觉感知. 这一发现表明,在抑郁症中,视觉处理和多巴胺基神经递质的潜在变化.
科学领域:
- 神经科学是一个神经科学.
- 心理学 心理学 心理学
- 眼科医生 眼科 眼科
背景情况:
- 重度抑郁症 (MDD) 与视觉感知变化有关,包括视网膜对比度增加减少和对比度值升高.
- 以前的研究表明,视觉处理缺陷可能会导致MDD的症状.
研究的目的:
- 通过评估对比度抑制来研究MDD中更高层次的视觉信息处理.
- 为了比较MDD和健康对照 (HC) 个体之间的对比抑制机制.
主要方法:
- 用一种心理物理测试来检查21名MDD患者和23名HC患者的对比抑制.
- 刺激包括不同的空间频率 (6.3和12.6cpd) 和背景对比 (30%和60%).
- 参与者在网格背景中调整了目标补丁的感知对比度.
主要成果:
- 患有MDD的患者比HC显著减少对比抑制,特别是在高刺激对比度 (p=0.006) 的情况下.
- 健康对照组显示较粗格子的对比抑制降低,而MDD患者的抑制不受空间特性的影响.
- 与HC相比,在MDD中观察到对比抑制的45%降低.
结论:
- 在MDD中减少对比抑制支持改变多巴胺基神经传递的理论.
- 研究结果表明,视网膜受体场或抑郁症适应机制的潜在功能障碍.
- 视觉处理变化可能在MDD的病理生理学中发挥作用.
相关概念视频
Depression: Overview
219
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
219
Depressive Disorders: MDD and Dysthymia
61
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
61
Antidepressant Drugs: MAOIs and Other Agents
195
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
195


